“These are exciting results, especially given our long-standing research, initially linking eosinophilic esophagitis (EoE) genetics to TSLP. These findings are anticipated to greatly advance patient care.” ~Marc Rothenberg, MD, PhD www.astrazeneca.com/media-centre...
Tezspire demonstrates positive Phase III results in eosinophilic esophagitis across both co-primary and all key secondary endpoints
astrazeneca.com